JIR
TNDM icon

James Investment Research’s Tandem Diabetes Care TNDM Stock Holding History

James Investment Research’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,315
Closed -$85K – 488
2020
Q1 		$85K Hold
1,315
– – 0.01% 271
2019
Q4 		$78K Hold
1,315
– – 0.01% 342
2019
Q3 		$78K Hold
1,315
– – 0.01% 383
2019
Q2 		$85K Buy
1,315
+180
+16% +$11.6K 0.01% 449
2019
Q1 		$72K Hold
1,135
– – ﹤0.01% 607
2018
Q4 		$43K Hold
1,135
– – ﹤0.01% 654
2018
Q3 		$49K Buy
+1,135
New +$39.6K ﹤0.01% 685

Other funds holding TNDM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

James Investment Research's TNDM Position: Q2 2020 in Review

James Investment Research sold out of Tandem Diabetes Care (TNDM) in Q2 2020, closing a stake of 1,315 shares — an estimated $85K sold.

James Investment Research first reported a position in TNDM in Q3 2018 and held it in 7 quarters. The position peaked at $85K in Q1 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2020.

  • James Investment Research reported no remaining Tandem Diabetes Care position as of Q2 2020 after selling out during the quarter.
  • James Investment Research sold 1,315 Tandem Diabetes Care shares in Q2 2020, an estimated $85K.
  • James Investment Research first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 7 quarters.
  • James Investment Research's Tandem Diabetes Care position peaked at $85K in Q1 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2020.

Based on James Investment Research's 13F filing for Q2 2020, filed 24 Jul 2020.